Health Wire Burundi: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Burundi.

Press releases published on November 4, 2026

Nov. 4, 2026

Neion Bio Taps John Maga as Head of Biologics and CMC to Expand Capabilities In Innovative Development

Indeterminate GlobeNewswire

Nov. 4, 2026

Standard Dental Labs Acquires M&D Dental Arts; Announces December 1 Launch Target for Bridge AI Software

Indeterminate GlobeNewswire

Nov. 4, 2026

Valneva to Report Nine-Month 2026 Consolidated Financial Results on November 24, 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Valneva publiera ses résultats financiers consolidés des neuf premiers mois de l’année le 24 novembre 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Banner MD Anderson marks 15 years of exceptional cancer care

Indeterminate GlobeNewswire

Nov. 4, 2026

Tessera Therapeutics to Present New Preclinical Data Supporting its In Vivo Sickle Cell Disease Program and In Vivo CAR-T Applications at the 68th American Society of Hematology Annual Meeting

Indeterminate GlobeNewswire

Nov. 4, 2026

Moleculin Announces Acceptance of Annamycin Data for Presentation at the 2026 American Society of Hematology (ASH) Annual Meeting

Indeterminate GlobeNewswire

Nov. 4, 2026

Asgard Therapeutics announces publication in Immunity demonstrating induction of cancer-fighting tertiary lymphoid structures across seven tumor types – and will present new AT-108 biomarker data at SITC 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Ichnos Glenmark Innovation (IGI) to Present Updated Clinical Data for ISB 2001 (ABBV-2001) in Relapsed/Refractory Multiple Myeloma at 68th ASH Annual Meeting

Indeterminate GlobeNewswire

Nov. 4, 2026

Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting

Indeterminate GlobeNewswire

Nov. 4, 2026

J-Star Holding Co., Ltd. Provides Update on Capital Structure Authorization and Strategic Execution Timeline

Indeterminate GlobeNewswire

Nov. 4, 2026

ORYZON to Present Updated Positive Clinical Data for Iadademstat in Hematological Malignancies at ASH 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

AI in Life Sciences Market to Worth USD 69.34 Billion by 2031, at a CAGR of 26.3% – MarketsandMarkets™

Indeterminate GlobeNewswire

Nov. 4, 2026

Translational Data from Anal Cancer Patients Show Pelareorep Drives HPV-Specific Immune Responses, Supporting its Potential Across HPV-Driven Cancers

Indeterminate GlobeNewswire

Nov. 4, 2026

Metagenomi Therapeutics to Present Preclinical Data Supporting MGX-001, a Potential One-Time Therapy for Hemophilia A, in Oral Presentation at 68th American Society of Hematology Annual Meeting

Indeterminate GlobeNewswire

Nov. 4, 2026

Applied Biologics Announces Full Enrollment of BIOxHEAL™ Phase 3 Sentinel Safety Cohort

Indeterminate GlobeNewswire

Nov. 4, 2026

Immix Biopharma’s NXC-201 NEXICART-2 Interim Clinical Trial Results Selected for Oral Presentation at ASH 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Cullinan Therapeutics Announces Presentations for CLN-049, a FLT3 T Cell Engager, and Velinotamig, a BCMA T Cell Engager, at the 68th ASH Annual Meeting

Indeterminate GlobeNewswire

Nov. 4, 2026

Tangram Announces Oral Presentation of TGM-148 Preclinical Data Highlighting Context-Dependent Mechanism of Action at the American Society of Hematology (ASH) 2026 Annual Meeting

Indeterminate GlobeNewswire